{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:07:40Z","timestamp":1791180460705,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.mcna.2021.08.006","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T16:56:46Z","timestamp":1637600206000},"page":"187-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Infectious Complications of Injection Drug Use"],"prefix":"10.1016","volume":"106","author":[{"given":"Laura R.","family":"Marks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathanial S.","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen Y.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Durkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa B.","family":"Weimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.mcna.2021.08.006_bib2","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1377\/hlthaff.2015.1424","article-title":"Hospitalizations related to opioid abuse\/dependence and associated serious infections increased sharply, 2002-12","volume":"35","author":"Ronan","year":"2016","journal-title":"Health Aff (Millwood)"},{"issue":"22","key":"10.1016\/j.mcna.2021.08.006_bib6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.15585\/mmwr.mm6622a1","article-title":"Hospitalizations for endocarditis and associated health care costs among persons with diagnosed drug dependence - North Carolina, 2010-2015","volume":"66","author":"Fleischauer","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.mcna.2021.08.006_bib7","article-title":"Long-term infective endocarditis mortality associated with injection opioid use in the United States: a modeling study","author":"Barocas","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.006_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2105\/AJPH.2019.305366","article-title":"Opioid use fueling HIV transmission in an urban setting: an outbreak of hiv infection among people who inject drugs-Massachusetts, 2015-2018","volume":"110","author":"Alpren","year":"2020","journal-title":"Am J Public Health"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.006_bib9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/infdis\/jir196","article-title":"A\u00a0systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs","volume":"204","author":"Hagan","year":"2011","journal-title":"J\u00a0Infect Dis"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.006_bib10","doi-asserted-by":"crossref","first-page":"ofz539","DOI":"10.1093\/ofid\/ofz539","article-title":"Beyond antibiotics: a practical guide for the infectious disease physician to treat opioid use disorder in the setting of associated infectious diseases","volume":"7","author":"Seval","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.mcna.2021.08.006_bib11","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.15585\/mmwr.mm675152a3","article-title":"Wound botulism outbreak among persons who use black Tar Heroin \u2014 San Diego County, California, 2017\u20132018","volume":"67","author":"Peak","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8","key":"10.1016\/j.mcna.2021.08.006_bib12","first-page":"149","article-title":"Tetanus among injecting-drug users--California, 1997","volume":"47","year":"1998","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.006_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3201\/eid1901.120044","article-title":"Infections with spore-forming bacteria in persons who inject drugs, 2000-2009","volume":"19","author":"Palmateer","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.006_bib14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1155\/2015\/482309","article-title":"A\u00a0cluster of Bacillus cereus bacteremia cases among injection drug users","volume":"26","author":"Benusic","year":"2015","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"11","key":"10.1016\/j.mcna.2021.08.006_bib15","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1099\/0022-1317-51-11-1001","article-title":"An investigation into the microflora of heroin","volume":"51","author":"Mc","year":"2002","journal-title":"J\u00a0Med Microbiol"},{"issue":"6396","key":"10.1016\/j.mcna.2021.08.006_bib16","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/bmj.287.6396.861","article-title":"Disseminated candidiasis: evidence of a distinctive syndrome in heroin abusers","volume":"287","author":"Collignon","year":"1983","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"6","key":"10.1016\/j.mcna.2021.08.006_bib17","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/clind\/15.6.910","article-title":"Disseminated candidiasis in addicts who use brown heroin: report of 83 cases and review","volume":"15","author":"Bisbe","year":"1992","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.006_bib18","doi-asserted-by":"crossref","first-page":"ofw157","DOI":"10.1093\/ofid\/ofw157","article-title":"Increasing infectious endocarditis admissions among young people who inject drugs","volume":"3","author":"Wurcel","year":"2016","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"10.1016\/j.mcna.2021.08.006_bib19","first-page":"461","article-title":"Risk factors associated with skin and soft tissue infections among hospitalized people who inject drugs","volume":"11","author":"Phillips","year":"2017","journal-title":"J\u00a0Addict Med"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.006_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1086\/320879","article-title":"Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study","volume":"33","author":"Murphy","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mcna.2021.08.006_bib21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drugpo.2016.08.016","article-title":"Young people and injection drug use: is there a need to expand harm reduction services and support?","volume":"39","author":"Adamson","year":"2017","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.mcna.2021.08.006_bib22","first-page":"1","article-title":"Infections in injection drug users: the significance of oral bacteria and a comparison with bacteria originating from skin and environmental sources","author":"Kannangara","year":"2020","journal-title":"Drug Drug Abuse"},{"issue":"10","key":"10.1016\/j.mcna.2021.08.006_bib23","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1007\/s11606-005-0236-8","article-title":"A\u00a0case of polymicrobial endocarditis caused by anaerobic organisms in an injection drug user","volume":"20","author":"Oh","year":"2005","journal-title":"J\u00a0Gen Intern Med"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.006_bib24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ajic.2010.07.005","article-title":"Survival and transmission of community-associated methicillin-resistant Staphylococcus aureus from fomites","volume":"39","author":"Desai","year":"2011","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.mcna.2021.08.006_bib25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.drugalcdep.2016.11.029","article-title":"A\u00a0systematic review of injecting-related injury and disease among people who inject drugs","volume":"171","author":"Larney","year":"2017","journal-title":"Drug Alcohol Depend"},{"issue":"Suppl 5","key":"10.1016\/j.mcna.2021.08.006_bib26","doi-asserted-by":"crossref","first-page":"S429","DOI":"10.1093\/infdis\/jiaa149","article-title":"National public health burden estimates of endocarditis and skin and soft-tissue infections related to injection drug use: a review","volume":"222","author":"See","year":"2020","journal-title":"J\u00a0Infect Dis"},{"issue":"8","key":"10.1016\/j.mcna.2021.08.006_bib27","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/acem.12727","article-title":"Microbiology and initial antibiotic therapy for injection drug users and non-injection drug users with cutaneous abscesses in the era of community-associated methicillin-resistant Staphylococcus aureus","volume":"22","author":"Jenkins","year":"2015","journal-title":"Acad Emerg Med"},{"issue":"11","key":"10.1016\/j.mcna.2021.08.006_bib28","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1001\/jama.279.11.859","article-title":"Wound botulism associated with black tar heroin among injecting drug users","volume":"279","author":"Passaro","year":"1998","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.mcna.2021.08.006_bib29","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/cid\/cir005","article-title":"Recurrent wound botulism among injection drug users in California","volume":"52","author":"Yuan","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.006_bib30","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1378\/chest.120.2.562","article-title":"Clinical predictors of respiratory failure and long-term outcome in black tar heroin-associated wound botulism","volume":"120","author":"Sandrock","year":"2001","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.006_bib31","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3201\/eid1204.050599","article-title":"Tetanus in injecting drug users, United Kingdom","volume":"12","author":"Hahn\u00e9","year":"2006","journal-title":"Emerging Infect Dis"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.006_bib32","doi-asserted-by":"crossref","first-page":"ofaa089","DOI":"10.1093\/ofid\/ofaa089","article-title":"Septic arthritis and the opioid epidemic: 1465 cases of culture-positive native joint septic arthritis from 1990-2018","volume":"7","author":"Ross","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.006_bib33","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/PL00011954","article-title":"Spinal epidural abscess: a meta-analysis of 915 patients","volume":"23","author":"Reihsaus","year":"2000","journal-title":"Neurosurg Rev"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.006_bib34","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.3171\/2014.6.FOCUS14148","article-title":"Diagnosis and management of primary pyogenic spinal infections in intravenous recreational drug users","volume":"37","author":"Ziu","year":"2014","journal-title":"Neurosurg Focus"},{"issue":"5","key":"10.1016\/j.mcna.2021.08.006_bib35","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jacc.2018.10.082","article-title":"Clinical outcomes of infective endocarditis in injection drug users","volume":"73","author":"Rudasill","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.006_bib36","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/0002-9343(93)90059-X","article-title":"The febrile parenteral drug user: a prospective study in 121 patients","volume":"94","author":"Weisse","year":"1993","journal-title":"Am J Med"},{"issue":"10","key":"10.1016\/j.mcna.2021.08.006_bib37","doi-asserted-by":"crossref","first-page":"e2016228","DOI":"10.1001\/jamanetworkopen.2020.16228","article-title":"Association of Treatment with medications for opioid use disorder with mortality after hospitalization for injection drug use\u2013associated infective endocarditis","volume":"3","author":"Kimmel","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"11","key":"10.1016\/j.mcna.2021.08.006_bib38","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1093\/cid\/ciy924","article-title":"Addiction medicine consultations reduce readmission rates for patients with serious infections from opioid use disorder","volume":"68","author":"Marks","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.006_bib39","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/hep.31060","article-title":"Hepatitis C guidance 2019 update: American Association for the Study of Liver Diseases\u2013infectious diseases society of America recommendations for testing, managing, and treating hepatitis C virus infection","volume":"71","author":"Ghany","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2021.08.006_bib40","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.drugpo.2017.07.021","article-title":"High HCV cure rates for people who use drugs treated with direct acting antiviral therapy at an urban primary care clinic","volume":"47","author":"Norton","year":"2017","journal-title":"Int J Drug Policy"},{"issue":"Suppl 2","key":"10.1016\/j.mcna.2021.08.006_bib41","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1093\/cid\/cit301","article-title":"Hepatitis C virus reinfection following treatment among people who use drugs","volume":"57","author":"Grady","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.mcna.2021.08.006_bib42","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/jhm.2597","article-title":"Successful implementation of outpatient parenteral antimicrobial therapy at a medical respite facility for homeless patients","volume":"11","author":"Beieler","year":"2016","journal-title":"J\u00a0Hosp Med"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.006_bib43","doi-asserted-by":"crossref","first-page":"105","DOI":"10.12788\/jhm.3138","article-title":"Outpatient parenteral antimicrobial therapy in vulnerable populations-- people who inject drugs and the homeless","volume":"14","author":"Beieler","year":"2019","journal-title":"J\u00a0Hosp Med"},{"issue":"12","key":"10.1016\/j.mcna.2021.08.006_bib44","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1093\/jac\/dkq355","article-title":"Safe and successful treatment of intravenous drug users with a peripherally inserted central catheter in an outpatient parenteral antibiotic treatment service","volume":"65","author":"Ho","year":"2010","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"Supplement_2","key":"10.1016\/j.mcna.2021.08.006_bib45","doi-asserted-by":"crossref","first-page":"S331","DOI":"10.1093\/ofid\/ofz360.810","article-title":"742. The development, implementation, and feasibility of multidisciplinary treatment planning conference for individuals with unstable substance use disorders and active infections requiring prolonged antimicrobial therapy: the OPTIONS-DC model","volume":"6","author":"Strnad","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"10.1016\/j.mcna.2021.08.006_bib46","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/cid\/ciy722","article-title":"A\u00a09-point risk assessment for patients who inject drugs and require intravenous antibiotics: focusing inpatient resources on patients at greatest risk of ongoing drug use","volume":"68","author":"Eaton","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"15","key":"10.1016\/j.mcna.2021.08.006_bib47","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","article-title":"Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association","volume":"132","author":"Baddour","year":"2015","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.mcna.2021.08.006_bib48","doi-asserted-by":"crossref","first-page":"ofy132","DOI":"10.1093\/ofid\/ofy132","article-title":"Infectious diseases physicians\u2019 perspectives regarding injection drug use and related infections, United States, 2017","volume":"5","author":"Rapoport","year":"2018","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.006_bib49","doi-asserted-by":"crossref","first-page":"ofab009","DOI":"10.1093\/ofid\/ofab009","article-title":"High inpatient health care utilization and charges associated with injection drug use\u2013related infections: a cohort study, 2012\u20132015","volume":"8","author":"Rapoport","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"9","key":"10.1016\/j.mcna.2021.08.006_bib50","doi-asserted-by":"crossref","first-page":"ofy194","DOI":"10.1093\/ofid\/ofy194","article-title":"Outpatient parenteral antimicrobial therapy among people who inject drugs: a review of the literature","volume":"5","author":"Suzuki","year":"2018","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.006_bib51","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.idc.2020.06.009","article-title":"Outpatient antimicrobial treatment for people who inject drugs","volume":"34","author":"Hurley","year":"2020","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.mcna.2021.08.006_bib52","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11469-014-9511-4","article-title":"A\u00a0community care model of intravenous antibiotic therapy for injection drug users with deep tissue infection for \u201cReduce Leaving Against Medical Advice\u201d","volume":"13","author":"Jafari","year":"2015","journal-title":"Int J Ment Heal Addict"},{"issue":"6","key":"10.1016\/j.mcna.2021.08.006_bib53","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1093\/cid\/ciz654","article-title":"Outpatient parenteral antimicrobial therapy plus buprenorphine for opioid use disorder and severe injection-related Infections","volume":"70","author":"Fanucchi","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.006_bib54","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1128\/AAC.04550-14","article-title":"Extended-duration dosing and distribution of dalbavancin into bone and articular tissue","volume":"59","author":"Dunne","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.006_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40121-016-0103-4","article-title":"Oritavancin: a new lipoglycopeptide antibiotic in the treatment of gram-positive infections","volume":"5","author":"Brade","year":"2016","journal-title":"Infect Dis Ther"},{"issue":"7","key":"10.1016\/j.mcna.2021.08.006_bib56","doi-asserted-by":"crossref","first-page":"ofz274","DOI":"10.1093\/ofid\/ofz274","article-title":"Long-acting lipoglycopeptides: \u201cLineless Antibiotics\u201d for serious infections in persons who use drugs","volume":"6","author":"Morrisette","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"10.1016\/j.mcna.2021.08.006_bib57","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/phar.2389","article-title":"Advantages of outpatient treatment with long-acting lipoglycopeptides for serious gram-positive infections: a review","volume":"40","author":"Krsak","year":"2020","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.1016\/j.mcna.2021.08.006_bib58","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/cid\/ciy279","article-title":"Dalbavancin as primary and sequential treatment for gram-positive infective endocarditis: 2-year experience at the general hospital of Vienna","volume":"67","author":"Tobudic","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.006_bib59","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0002-9343(96)00070-8","article-title":"Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy","volume":"101","author":"Heldman","year":"1996","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.mcna.2021.08.006_bib60","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1808312","article-title":"Partial oral versus intravenous antibiotic treatment of endocarditis","volume":"380","author":"Iversen","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl 2","key":"10.1016\/j.mcna.2021.08.006_bib61","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1093\/clinids\/13.Supplement_2.S160","article-title":"Antibiotic management of outpatients with endocarditis due to penicillin-susceptible streptococci","volume":"13","author":"Stamboulian","year":"1991","journal-title":"Rev Infect Dis"},{"issue":"5","key":"10.1016\/j.mcna.2021.08.006_bib62","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJMoa1710926","article-title":"Oral versus intravenous antibiotics for bone and joint infection","volume":"380","author":"Li","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.mcna.2021.08.006_bib63","doi-asserted-by":"crossref","first-page":"e650","DOI":"10.1093\/cid\/ciaa365","article-title":"Evaluation of partial oral antibiotic treatment for persons who inject drugs and are hospitalized with invasive infections","volume":"71","author":"Marks","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.mcna.2021.08.006_bib64","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/jamainternmed.2020.0555","article-title":"Evaluation of a paradigm shift from intravenous antibiotics to oral step-down therapy for the treatment of infective endocarditis: a narrative review","volume":"180","author":"Spellberg","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"5","key":"10.1016\/j.mcna.2021.08.006_bib65","doi-asserted-by":"crossref","first-page":"339","DOI":"10.12788\/jhm.2736","article-title":"Planning and designing the improving addiction care team (IMPACT) for hospitalized adults with substance use disorder","volume":"12","author":"Englander","year":"2017","journal-title":"J\u00a0Hosp Med"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712521001140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712521001140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:45:47Z","timestamp":1758419147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712521001140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0025712521001140"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2021.08.006","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infectious Complications of Injection Drug Use","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2021.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}